Bartels; Bjorn

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bartels; Bjorn.The latest application filed is for "synthesis of trans-8-chloro-5-methyl-1 -[4-(pyridin-2-yloxy)-cyclohexyl]-5,6-dihydro-4h-2,3,5,10b-tetraaza-benzo- [e]azulene and crytalline forms thereof".

Company Profile

0.6.11

Bartels; Bjorn - Schopfheim DE
Bartels; Bjorn - Radolfzell DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Synthesis Of Trans-8-chloro-5-methyl-1 -[4-(pyridin-2-yloxy)-cyclohexyl]-5,6-dihydro-4h-2,3,5,10b-tetraaza-benzo- [e]azulene And Crytalline Forms Thereof App 20210284648 - Rothenhaeusler; Benno ; et al.	2021-09-16
Synthesis of trans-8-chloro-5-methyl-1-[4-(pyridin-2-yloxy)-cyclohexyl]-5,6-dihydro-4H- -2,3,5,10B-tetraaza-benzo[e]azulene and crytalline forms thereof Grant 11,040,977 - Rothenhaeusler , et al. June 22, 2	2021-06-22
Bridged piperidine derivatives Grant 10,604,517 - Baumann , et al.	2020-03-31
Synthesis Of Trans-8-chloro-5-methyl-1 -[4-(pyridin-2-yloxy)-cyclohexyl]-5,6-dihydro-4h-2,3,5,10b-tetraaza-benzo- [e]azulene And App 20190194210 - Rothenhaeusler; Benno ; et al.	2019-06-27
Synthesis of trans-8-chloro-5-methyl-1-[4-(pyridin-2-yloxy)-cyclohexyl]-5,6-dihydro-4H- -2,3,5,10B-tetraaza-benzo[E]azulene and crytalline forms thereof Grant 10,246,460 - Rothenhaeusler , et al.	2019-04-02
Bridged Piperidine Derivatives App 20180237432 - Baumann; Karlheinz ; et al.	2018-08-23
Synthesis Of Trans-8-chloro-5-methyl-1 -[4-(pyridin-2-yloxy)-cyclohexyl]-5,6-dihydro-4h-2,3,5,10b-tetraaza-benzo- [e]azulene And Crytalline Forms Thereof App 20160280712 - Rothenhaeusler; Benno ; et al.	2016-09-29
Tetrahydrobenzothiophene Derivatives App 20110044938 - Bartels; Bjorn ; et al.	2011-02-24
Tetrahydropyridothiophenes For The Treatment Of Proliferative Diseases Such As Cancer App 20100324038 - Pekari; Klaus ; et al.	2010-12-23
Tetrahydropyridothiophenes as antiproliferative agents for the treatment of cancer Grant 7,741,488 - Pekari , et al. June 22, 2	2010-06-22
Tetrahydropyridothiophenes Grant 7,723,523 - Pekari , et al. May 25, 2	2010-05-25
Tetrahydropyridothiophenes for the treatment of proliferative diseases such as cancer Grant 7,714,135 - Pekari , et al. May 11, 2	2010-05-11
Tetrahydropyridothiophenes As Antripoliferative Agents For The Treatment Of Cancer App 20090252706 - Pekari; Klaus ; et al.	2009-10-08
Tetrahydropyridothiophenes For The Treatment Of Proliferative Diseases Such As Cancer App 20090227577 - PEKARI; Klaus ; et al.	2009-09-10
Tetrahydropyridothiophenes as Antiproliferative Agents for the Treatment of Cancer App 20090098133 - Pekari; Klaus ; et al.	2009-04-16
Tetrahydropyridothiophenes for the Treatment of Proliferative Diseases Such as Cancer App 20080096914 - Pekari; Klaus ; et al.	2008-04-24
Novel tetrahydropyridothiophenes App 20070244112 - Pekari; Klaus ; et al.	2007-10-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.